Lung Cancer Trial, Recruiting NCT06076005 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT06076005
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have a suspected lung cancer based on medical imaging such as a CT scan and/or a PET/CT scan
  • People for whom a biopsy has been recommended for diagnosis, staging, and/or testing the tumour's genetic profile

Who may not be able to join:

  • People who are unable or unwilling to sign a written consent form to participate
  • People whose overall health and physical functioning is too poor (as assessed by their doctor using a standard scale) to safely undergo a tissue biopsy
  • People classified as ASA 4 status, meaning they have a severe medical condition that makes procedures particularly high risk (confirm with trial site)
  • People whose cancer has been staged as Stage I, II, or III (this trial appears to focus on other stages — confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rocco Trisolini, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: 0630154163

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 November 2023
Est. completion
31 May 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Distribution of histologic subtypes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov